Currently available influenza vaccines are of the injectable type, which induce systemic IgG responses but not mucosal IgA responses; such vaccines mitigate the severity of disease following virus infection but cannot prevent infection in the first place [4]. The gene discussed is CD79A; the disease is influenza.